Symbiosis Pharmaceutical

Activities: Manufacturing

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Finance

Symbiosis begins commercial manufacturing at new FDA-inspected facility

Symbiosis Pharmaceutical Services (Symbiosis), a leading sterile fill-finish contract manufacturing organisation (CMO), has manufactured its first 10,000-vial batch at the company’s new facility in Stirling, UK
Manufacturing

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded
Manufacturing

Symbiosis reaches major milestone with 1,000th batch of injectable drug product

Symbiosis Pharmaceutical Services, a global contract manufacturing organisation (CMO), today announced the successful completion of its 1,000th sterile drug product batch, marking a significant milestone in its mission to accelerate access to life-changing medicines worldwide
Manufacturing

Symbiosis appoints Angelika Rublack as Senior Business Development Manager

Symbiosis expands global reach with key appointment of Angelika Rublack as Senior Business Development Manager

Symbiosis honoured with prestigious King’s Award for Enterprise for International Trade

Symbiosis Pharmaceutical Services (Symbiosis), a global biopharmaceutical Contract Manufacturing Organisation (CMO) specialising in the sterile fill finish of injectable drug products has been awarded a 2025 King’s Award for Enterprise in the International Trade category, the UK’s highest official accolade for British businesses
Manufacturing

Symbiosis completes successful MHRA audit of new sterile fill/finish facility

Symbiosis completes successful MHRA audit of new sterile fill/finish facility, expanding global manufacturing capacity
Regulatory

Quality and compliance: the foundation of trust

As the CEO of Symbiosis, a contract manufacturing organisation (CMO) licenced to manufacture sterile medicinal products, Colin MacKay understands the profound responsibility involved in ensuring that the products they manufacture meet the highest quality standards and adhere to all relevant regulatory requirements
Subscribe now